PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.86%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
18.18%
D&A growth well above VUZI's 22.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
53.33%
Deferred tax of 53.33% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-21.67%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
119.90%
AR growth while VUZI is negative at -73.35%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-181.82%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-135.19%
Both negative yoy AP, with VUZI at -192.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
20.83%
Lower 'other working capital' growth vs. VUZI's 352.14%. David Dodd would see fewer unexpected short-term demands on cash.
175.00%
Well above VUZI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
25.00%
Some CFO growth while VUZI is negative at -38.64%. John Neff would note a short-term liquidity lead over the competitor.
-76.47%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
2.17%
Purchases growth of 2.17% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-6.90%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-97.67%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-60.00%
Negative yoy issuance while VUZI is 124.06%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.